Composition: Bortezomib 3.5mg
Availability of this product will assure once the Pharmacy partners is confirmed.
Myezom 3.5mg injection is used in the treatment of multiple myeloma and mantle-cell lymphoma.
Bortezomib belongs to the class of drugs called proteasome inhibitors. Proteasomes are proteins which play an important role in growth and multiplication of cancer cells. Bortezomib blocks the action of proteasome, and reduces the growth of cancerous (actively growing) cells..
Reduced blood platelets, Psychiatric disturbances, Vomiting, Nausea, Loss of appetite, Fever, Anemia, Diarrhoea, Peripheral neuropathy (tingling and numbness of feet and hand), Decreased appetite, Low energy, Decreased white blood cell count (neutrophils), Constipation.